• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠中紫铆因、2',3,4-三羟基查耳酮、3-O-甲基紫铆因、4-O-甲基紫铆因和2',4',4-三羟基查耳酮的代谢与排泄

Metabolism and excretion of butein, 2',3,4-trihydroxychalcone, 3-O-methylbutein, 4-O-methylbutein and 2',4',4-trihydroxychalcone in the rat.

作者信息

Brown S, Griffiths L A

出版信息

Xenobiotica. 1983 Nov;13(11):669-82. doi: 10.3109/00498258309052228.

DOI:10.3109/00498258309052228
PMID:6673378
Abstract

Butein (2',3,4,4'-tetrahydroxychalcone) and 2',3,4-trihydroxychalcone, following administration to bile-duct-cannulated rats, gave rise to the corresponding 3-O-methyl ethers which were excreted in conjugated forms in bile and urine. After parenteral and oral administration of [14C]butein, 53% and 20% of the dose, respectively, was excreted in bile in 24h. After oral administration of [14C]butein, 4-O-methylbutein, or 2',4',4-trihydroxychalcone to non-cannulated rats, 51%, 58% and 40% dose, respectively, was excreted in faeces, and 39%, 37% and 56%, respectively, in urine. Intraperitoneal administration of butein to non-cannulated rats led to excretion of 41% dose in urine and 56% in faeces. 3-O-Methylbutein and 4-O-methylbutein were demethylated in vivo and on incubation with rat-intestinal microflora in vitro, whilst 2',4-dihydroxy-3-methoxychalcone and 2',3-dihydroxy-4-methoxychalcone were not demethylated in vivo or in vitro. Following parenteral and oral administration of 4-O-methylbutein to bile-duct-cannulated rats, 91% and 21% dose, respectively, was excreted in the bile in 24h. After parenteral or oral administration of 2',4',4-trihydroxychalcone to cannulated rats, approx. 100% and 45% dose, respectively, was excreted in the bile in 24h. Trace amounts of 2',4',4-trihydroxychalcone were hydroxylated to give butein.

摘要

将布替因(2',3,4,4'-四羟基查耳酮)和2',3,4-三羟基查耳酮给予胆管插管大鼠后,会产生相应的3-O-甲基醚,这些醚以结合形式在胆汁和尿液中排泄。经肠胃外和口服给予[14C]布替因后,24小时内分别有53%和20%的剂量经胆汁排泄。给非插管大鼠口服[14C]布替因、4-O-甲基布替因或2',4',4-三羟基查耳酮后,分别有51%、58%和40%的剂量经粪便排泄,39%、37%和56%分别经尿液排泄。给非插管大鼠腹腔注射布替因后,41%的剂量经尿液排泄,56%经粪便排泄。3-O-甲基布替因和4-O-甲基布替因在体内以及与大鼠肠道微生物群体外孵育时会发生去甲基化,而2',4-二羟基-3-甲氧基查耳酮和2',3-二羟基-4-甲氧基查耳酮在体内或体外均未发生去甲基化。给胆管插管大鼠经肠胃外和口服给予4-O-甲基布替因后,24小时内分别有91%和21%的剂量经胆汁排泄。给插管大鼠经肠胃外或口服给予2',4',4-三羟基查耳酮后,24小时内分别约有100%和45%的剂量经胆汁排泄。痕量的2',4',4-三羟基查耳酮会被羟基化生成布替因。

相似文献

1
Metabolism and excretion of butein, 2',3,4-trihydroxychalcone, 3-O-methylbutein, 4-O-methylbutein and 2',4',4-trihydroxychalcone in the rat.大鼠中紫铆因、2',3,4-三羟基查耳酮、3-O-甲基紫铆因、4-O-甲基紫铆因和2',4',4-三羟基查耳酮的代谢与排泄
Xenobiotica. 1983 Nov;13(11):669-82. doi: 10.3109/00498258309052228.
2
The metabolism and excretion of 3-O-methyl-(+)-catechin in the rat, mouse, and marmoset.3 - O - 甲基 -(+)- 儿茶素在大鼠、小鼠和狨猴体内的代谢与排泄。
Drug Metab Dispos. 1981 Jan-Feb;9(1):54-9.
3
Absorption and elimination of (14C) hesperidin methylchalcone in the rat.大鼠体内(14C)橙皮苷甲基查耳酮的吸收与消除
Eur J Drug Metab Pharmacokinet. 1981;6(3):171-7. doi: 10.1007/BF03189486.
4
The influences of the route of administration on the metabolism and excretion of bitolterol, a new bronchodilator, in the rat.给药途径对新型支气管扩张剂双甲苯喘定在大鼠体内代谢及排泄的影响。
Xenobiotica. 1979 Mar;9(3):173-80. doi: 10.3109/00498257909038718.
5
Enterohepatic circulation in rat and dog of 14C-0-[3-(4-less than 2-methoxyphenyl greater than-1-piperazinyl)-2-hydroxypropyl]-3-methoxy-benzaldoxim dihydrochloride and it's demethylated metabolite.大鼠和犬体内14C-0-[3-(4-(2-甲氧基苯基)-1-哌嗪基)-2-羟丙基]-3-甲氧基苯甲醛肟二盐酸盐及其去甲基代谢物的肠肝循环
Eur J Drug Metab Pharmacokinet. 1981;6(4):303-12. doi: 10.1007/BF03189530.
6
The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.抗蠕虫药甲基-14C-5-环丙基羰基-2-苯并咪唑氨基甲酸酯(环苯达唑)对大鼠和犬给药后的放射性分布情况。
Arzneimittelforschung. 1977;27(3):593-8.
7
Dihydrochalcone metabolism in the rat: phloretin.大鼠体内二氢查耳酮的代谢:根皮素
Xenobiotica. 1984 Dec;14(12):917-24. doi: 10.3109/00498258409151490.
8
The absorption and excretion of the peripheral vasodilator 14C-mecinarone, (14C-6809 MD) in rat, dog and man.外周血管扩张剂14C-美西那酮(14C-6809 MD)在大鼠、狗和人体中的吸收与排泄。
Eur J Drug Metab Pharmacokinet. 1980;5(3):135-43. doi: 10.1007/BF03189457.
9
Dihydrochalcone metabolism in the rat: trihydroxylated derivatives related to phloretin.大鼠体内二氢查耳酮的代谢:与根皮素相关的三羟基化衍生物
Xenobiotica. 1986 Jan;16(1):35-45. doi: 10.3109/00498258609043503.
10
Disposition of [14C]methyl bromide in Fischer-344 rats after oral or intraperitoneal administration.
Toxicology. 1984 Sep 14;32(3):187-96. doi: 10.1016/0300-483x(84)90073-8.

引用本文的文献

1
Mitochondrial Role in Intrinsic Apoptosis Induced by a New Synthesized Chalcone in Hepatocellular Carcinoma Cells.线粒体在新合成查耳酮诱导的肝癌细胞内源性凋亡中的作用
Biomedicines. 2022 Dec 2;10(12):3120. doi: 10.3390/biomedicines10123120.
2
Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.植物药在 COVID-19 住院患者凝血功能障碍管理中的潜在临床应用。
Phytother Res. 2022 May;36(5):1884-1913. doi: 10.1002/ptr.7408. Epub 2022 Feb 11.
3
Evaluation of potential antidepressant-like activity of chalcone-1203 in various murine experimental depressant models.
评价查尔酮 1203 在多种小鼠实验性抑郁模型中的潜在抗抑郁样活性。
Neurochem Res. 2014 Feb;39(2):313-20. doi: 10.1007/s11064-013-1224-8. Epub 2013 Dec 17.